FDA product code JNL: Immunochemical, Thyroglobulin Autoantibody
JNL is the FDA product code for immunochemical, thyroglobulin autoantibody. It is a Class II device, regulated under 21 CFR 866.5870 and reviewed by the Immunology panel. FDA has cleared 22 510(k) submissions under JNL, 2 in the last five years, from 12 different applicants. The average 510(k) review took 111 days (median 83); 172 days on average over the last three years. FDA has posted 4 recalls for JNL devices, 1 initiated in the last five years.
Classification
| Field | Value |
|---|---|
| Device name | Immunochemical, Thyroglobulin Autoantibody |
| Device class | Class II |
| Regulation | 21 CFR 866.5870 |
| Review panel | IM — Immunology |
| Medical specialty | Immunology |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
510(k) clearances per year for JNL
| Year | Clearances | Avg. review days |
|---|---|---|
| 2024 | 1 | 83 |
| 2025 | 1 | 261 |
Compare with all 510(k) review times · Search every JNL clearance
Top JNL applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Immunoprobe, Inc. | 4 | 1995-11-20 |
| Beckman Coulter, Inc. | 3 | 2024-07-03 |
| Cogent Diagnotics , Ltd. | 3 | 1995-04-17 |
| Hycor Biomedical, Inc. | 2 | 1996-11-25 |
| Organon Teknika Corp. | 2 | 1995-08-25 |
7 more applicants have JNL clearances. See the full list in Caduvo.
Most recent JNL clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K250816 | Siemens Healthcare Diagnostics, Inc. | ADVIA Centaur Anti-Thyroglobulin II (aTgII) | 2025-12-04 | 261 |
| K240996 | Beckman Coulter, Inc. | Access Thyroglobulin Antibody II | 2024-07-03 | 83 |
| K112933 | Beckman Coulter, Inc. | ACCESS THYROGLOBULIN ANITBODY | 2011-12-27 | 85 |
| K072661 | Phadia US, Inc. | IMMUNOCAP THYRLOBULIN IMMUNOCAP | 2007-11-20 | 60 |
| K062516 | Beckman Coulter, Inc. | ACCESS THYROGLOBULIN ANTIBODY II ASSAY, MODELS A32898 (REAGENT) AND A36920 (CALIBRATORS) | 2006-10-05 | 38 |
Recalls for JNL devices
4 product recalls in 4 recall events; 1 initiated in the last five years and 1 still open. Most recent: 2024-09-05.
| Year | Recalls |
|---|---|
| 2019 | 1 |
| 2024 | 1 |
Frequently asked questions
What is FDA product code JNL?
JNL is the FDA product code for immunochemical, thyroglobulin autoantibody. It is a Class II device, regulated under 21 CFR 866.5870 and reviewed by the Immunology panel.
What device class is JNL?
Class II, regulation 21 CFR 866.5870. Typical premarket route: 510(k).
How long does a 510(k) take for product code JNL?
Across 22 cleared submissions the average was 111 days from receipt to decision (median 83).
Which companies have the most JNL clearances?
Immunoprobe, Inc. (4); Beckman Coulter, Inc. (3); Cogent Diagnotics , Ltd. (3); Hycor Biomedical, Inc. (2); Organon Teknika Corp. (2).
Have JNL devices been recalled?
Yes: 4 product recalls across 4 recall events; the most recent began 2024-09-05.
Next steps
- Run an FDA pathway report with predicate devices for product code JNL
- Run a recall and safety report across every JNL manufacturer
- Watch product code JNL for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Immunology product codes · FDA product code lookup · 510(k) database search · 510(k) review times